Blog | Antidote (62)

ePRO in clinical trials: To BYOD or not to BYOD?

Electronic patient-reported outcomes (ePRO) in clinical trials effectively gather data and include the patient's voice while reducing the burden of ...

Patients as Partners Hits on What Matters Most: Patient Centricity

In my role at Antidote, I talk to advocacy groups and patient organizations every day, so I have a good sense of patient involvement in the drug ...

Antidote and the American Liver Foundation (ALF) announce partnership to accelerate liver disease research

Today, liver disease affects 30 million people in the US — one in 10 Americans. And unfortunately, that number is on the rise. To address this ...

5 ePRO clinical trial best practices

In clinical trials, electronic patient-reported outcomes (ePRO) can be used to capture the patient experience in a way that's accessible for patients ...

IWRS vs. RTSM: What's the difference in clinical research?

Interactive Web Response Systems (IWRS) are the technology that clinical trial site managers use to randomize patients and manage drug supplies for a ...

The Special Diabetes Program: How JDRF leads the charge for diabetes research

In 2023, legislation was approved to restore previous budget cuts to the Special Diabetes Program (SDP), a key program that funds diabetes research ...

Medical Pioneers: Meet Erica Barnes, rare disease advocate

“I have a vision of a world where every single child with a rare disease has a treatment option," said Erica Barnes, founder of Chloe's Fight Rare ...

What features do ePRO vendors offer today?

Electronic patient-reported outcomes (ePRO) allow studies to capture patient information through tablets, smartphones, or other devices. ePRO is a ...